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Objective: Determine the prevalence of latent TB infection in HIV-infected people.
Method: Using a cross-sectional study on HIV-infected persons monitored in the Depart-
ment of Lung and Infectious Diseases of CHU Sylvanus Olympio of Lome´ from August 10,
2010 to November 10, 2010. All patients are receiving anti-retroviral therapy and have no
clinical or radiological symptoms of TB, and had never received tuberculin skin test
(TST) in the last 3 months. The CD4 rate of all patients was more than 200 cells/ll. The diag-
nosis of latent TB infection is based on the measurement of at least 5 mm of skin indura-
tion, 72 h after a subcutaneous injection of 5 IU of purified tuberculin.
Results: One hundred and fifty four persons were included in the study, of which 107 were
female and 47 were male. The median age was 40 years old. Eleven patients were exposed
to a risk of TB and only 70.7% of patients had a BCG scar. A suspicion of former TB was
found in 18.8% of patients and approximately 45% of patients were very immunocompro-
mised with a CD4 rate between 200 and 350; 117 patients had a positive TST. This repre-
sents an overall prevalence of 76% of latent TB infection.
Conclusion: The prevalence of latent TB infection obtained with the TST is high in this
study. A similar study using the interferon-gamma release assay, which is more specific,
would be more helpful to obtain more reliable epidemiological data on patient outcomes
and to determine the appropriateness of the use of chemoprophylaxis with isoniazid.
 2012 Asian-African Society for Mycobacteriology. All rights reserved.Introduction
Latent TB infection is an infection without clinical, bacterio-
logical and radiological signs. This is typically a person who
has a positive tuberculin skin test (TST) with normal chest
radiograph [1]. The diagnosis of latent tuberculosis (TB) re-
mains unclear. The main problem with the test is its low spec-
ificity. The interpretation must consider the possibility of false
positives [2]. These are mainly due to former vaccination with
BCG or infection with non-tuberculosis mycobacteria. The TST
should be performed with the intention of detecting and treat--African Society for Myco
, Lome´, Togo. Tel.: +228 9
ateba).ing latent tuberculosis. Mass screening is not recommended.
In fact, the positive predictive value of the TST is even lower
if the prevalence of TB infection in the tested group is low,
hence the need to test only risk cases. In Africa, HIV infection
is the greatest risk factor to developing TB [3–5]. However, de-
spite the fact that TB/HIV co-infection is increasing more
and more, no chemoprophylaxis of latent TB infection with
isoniazid among people with TST of more than 5 mm is not
yet applied. This first study of its kind in Togo aims to provide
preliminary data on the prevalence of latent TB infection in
people with HIV to be a basis for target strategy. Moreover, thisbacteriology. All rights reserved.
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Table 1 – General characteristics of the population at
baseline.
Parameters Value/number Proportion
Epidemiological characteristics
Total 154 100%
Median age in years (range) 40 (18–64) –
Sex M/F 107/47 –
Suspicion of contagion 11 7.14
BCG scar 109 70.7
History of tuberculosis 29 18.8
Immunological characteristics
CD4 count between 200
and 350 cells/ll
69 44.8
CD4 count P350 cells/ll 85 55.2
Table 2 – Characteristics of the population according to the
tuberculin skin test (TST).
Parameters Value/number Proportion
Positive TST with BCG scar 83/109 76.1
Positive TST without BCG scar 34/45 75.6
Positive TST with suspicion of
contagion of TB
26/29 89.7
Positive TST without suspicion
ofcontagion of TB
91/125 72.8
Positive TST with CD4 rate
<350 cells/ll
54/69 78.3
Positive TST with CD4 rate
>350 cells/ll
63/85 74.1
p(BCG) = 0.938; p(contagion TB) = 0.556; p(CD4) = 0.443.
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lence of latent TB infection among HIV-infected persons.
Methods
This is a cross-sectional study on a group of HIV-infected per-
sons monitored in the Ambulatory Treatment Center (ATC) of
the Department of Respiratory and Infectious Diseases at the
Sylvanus Olympio University Hospital (CHU SO) of Lome´ be-
tween the period August 10, 2010 to November 10, 2010. All
patients are adults and aged at least 18 years and are receiv-
ing antiretroviral therapy. All patients have not developed
any clinical or radiological symptoms of TB and have never
received a TST in the 3 months prior to the study period. In
addition, no patient received immunosuppressive therapy,
and the CD4 count of all patients was more than 200 cells/
ll. The TST consisted of the subcutaneous administration of
five international units of purified tuberculin. The measure-
ment of the induration was made 72 h after the injection.
The test is considered positive if the induration measurement
is over 5 mm. A chest radiograph was performed on all pa-
tients who were exposed to a risk of TB or had been declared
cured of a former case of TB. The exposition of a risk of TB,
the appreciation of TB history of vaccination by the BCG scar,
and the CD4 count were the main studied parameters.
The statistical analysis was performed with SPSS software
and the chi-2 test has allowed comparing qualitative vari-
ables. A p value less than 0.05 was considered statistically
significant.
Results
A total of 154 people were included in the study. More than
60.4% of patients were aged between 25 and 44 years with a
female predominance (sex ratio 0.44). A total of 11 patients
were exposed to a risk of TB and only 70.7% of patients had
a BCG scar. A suspicion of former TB was found in 18.8% of
patients and approximately 45% of patients were very immu-
no-compromised with a CD4 count between 200 and 350 cells/
ll (Table 1).
A total of 117 patients had a positive TST. This represents
an overall prevalence of 76% of latent TB infection (Table 2).
Discussion
The diagnosis of latent TB infection based on the delayed
hypersensitivity test is based on a specific cell-mediated re-
sponse [6,7].
Thus, according to international recommendations, the
test is considered positive when the skin reaction is at least
5 mm for those HIV infected [8]. But, in HIV-uninfected peo-
ple, the TST becomes significant in the case of phlyctenular
reaction, or if the induration reaches 15 mm within a popula-
tion with low-risk factors of TB [2]. Nowadays, the TST re-
mains – despite its lack of specificity – the cheapest and
most widely used test in the diagnosis of latent TB infection.
However, the interferon-gamma release assay (IGRA), which
is more specific to measure cell-mediated responses, is avail-
able today on the market. The major advantage of the IGRAtest is its increased specificity in the diagnosis of latent TB
infection among populations vaccinated with BCG. This situ-
ation applies to immunocompetent adults with a positive TST
in the context of very low risk of TB infection [9]. The preva-
lence of latent TB infection is high in this study (76%). This
situation is found in most studies in developing countries
where the prevalence can reach 90% of subjects living with
HIV. However, in developed countries, the prevalence is rela-
tively low [10,11]. The reasons for this disparity would be
linked to the prevalence of TB in these different regions of
the world. In fact, most of the new cases of TB and HIV diag-
nosed each year are found in the third world. In this study, the
prevalence is probably exaggerated because the vast majority
of patients who have been vaccinated and who still bear the
scars of BCG may have a positive TST. This is due to the fact
that even though the previous vaccination of this population
was done 20 years before, it can still provide antibodies. How-
ever, the results of the study showed no significant difference
between people vaccinated with BCG scar and unvaccinated
ones (Table 2; p = 0.938). The TB immunity with BCG is known
to decrease with age [12,13]. Similarly, the suspicion of conta-
gion of TB had no impact on the positivity of the TST
(p = 0.556). In fact, this element was very subjective and diffi-
cult to measure. In addition, false skin positive reactions can
also come from atypical mycobacteria. The diagnosis may
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factor of inaccessibility.
The immune status assessed according to CD4 rate has not
had a significant impact on the result of the TST, whether it
be patients whose CD4 count was between 200 and
350 cells/ll or those whose CD4 rates was above 350 cells/ll
(p = 0.443). Indeed, patients were excluded from the study
whose CD4 rate was under 200 cells/ll because the progres-
sion to end-stage of HIV can promote reactivation of latent
TB bacilli contrasting with the frequent energy of TB which
can be observed with these patients. Thus, both the TST
and the IGRA would not be good tests for assessing latent
TB infection in those immuno-compromised by HIV [14]. It
is also for this reason that the tuberculin skin induration of
5 mm is sufficient to diagnose latent TB in those HIV infected
regardless of the CD4 rate. But, in people free from any risk
factors, the TST reaction becomes significant when the mea-
sure of the induration is at least 15 mm in diameter [2].
No patient received treatment for latent TB. Indeed,
although international guidelines recommend starting treat-
ment of latent TB infection in high-risk persons, in Togo,
the national strategy has not yet integrated it. The reasons
are the difficulties of getting patients to accept taking medica-
tion for a period of 6 months while they are fully asymptom-
atic. This would decrease observance of the treatment which,
in turn, would cause the emergence of multi-resistant myco-
bacteria of which treatment is difficult and too expensive.
Conclusion
The latent TB infection is a poorly elucidated problem in Togo
where TB and HIV are endemic. The results obtained in this
study show the extent of what could be done in order to find
solutions to reduce the incidence of TB disease. The TST,
although somewhat unspecific, can represent an excellent
screening test in developing countries with limited resources;
although IGRA is more specific to the latent TB diagnosis, it is
also very expensive.
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